Podimetrics, an organization that helps sufferers with diabetes stop critical problems, is teaming up with HealthMed, an worker well being and wellness platform.
HealthMed goals to combine Podimetrics’ SmartMat expertise into its portfolio of advantages supposed for giant employers, hospitals and municipalities. The corporate additionally gives worker wellness and psychological well being packages.
Podimetrics’ SmartMat measures the foot temperature of high-risk sufferers and scans for early indicators of irritation that might result in wounds, amputations and diabetic foot ulcers.
“Our partnership with HealthMed is a powerful collaboration, and we’re excited to work collectively to assist people with advanced diabetes who’re on the best threat for critical problems,” Dr. Jon Bloom, CEO of Podimetrics, stated in a press release.
“We share a typical mission to give attention to prevention and enhance well being outcomes. This collaboration is aimed toward reaching that purpose collectively.”
Tracy Webster, founding father of HealthMed, stated the partnership with Podimetrics and its modern resolution for managing sophisticated diabetes will profit self-insured employers and enhance the continuum of care.
“We stay up for the constructive influence we are able to make on well being outcomes and the general price of care,” Webster stated in a press release.
THE LARGER TREND
In March, Podimetrics partnered with profit administration group Alivi Well being, which integrated SmartMat expertise into its portfolio of specialty advantages to bolster its podiatry advantages for well being plans and payers.
In 2024, Podimetrics sued Eire-based Bluedrop Medical for patent infringement. Bluedrop has a tool that permits an individual with diabetes to scan their ft for potential situations of foot ulcers.
Based on the compliant, Bluedrop allegedly “instantly and/or by subsidiaries, workers, intermediaries or commerce names” dedicated acts of infringement by “importing, providing to promote and promoting an instrumentality that infringes [Podimetrics’] Patents-in-Swimsuit.” The case was dismissed after Podmetrics withdrew its declare.
In 2022, Podimetrics scored $45 million in a Sequence C financing spherical. The capital was used to increase Podimetrics’ product growth and analysis groups in addition to enhance the variety of providers offered by its nurse assist groups.
In 2019, Podimetrics raised $13.4 million in Sequence B funding. Rock Well being, Norwich Ventures and Scientific Well being Improvement participated within the spherical.
Different firms within the diabetes area embody Dexcom, which in 2024 made a $75 million strategic funding in health-tracking ring maker Oura and established a strategic partnership to allow two-way information move between Dexcom’s steady glucose monitor (CGM) and the Oura Ring. Dexcom’s $75 million funding introduced Oura’s valuation to greater than $5 billion.
Diabetes and insulin administration software program firm Glytec and pharmaceutical agency Roche joined forces final 12 months to permit using Glytec’s software program in reference to Roche’s point-of-care smart-device hospital blood glucose system cobas pulse within the U.S. and international markets.
Based on Roche, cobas pulse’s strip structure gives lab-like outcomes and lowers the necessity to repeat assessments. The system can be utilized on all affected person populations, together with neonates and intensive care sufferers.
Discussion about this post